Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasia
Journal
The journal of allergy and clinical immunology. Global
Journal Volume
2
Journal Issue
4
Date Issued
2023-11
Author(s)
Abstract
Infants with respiratory-syncytial virus bronchiolitis hospitalization are more likely to develop wheezing and subsequent asthma. Reportedly, palivizumab prophylaxis effectively prevents respiratory-syncytial virus hospitalization in high-risk children-such as premature infants or infants with bronchopulmonary dysplasia (BPD).
Subjects
Asthma; RSV bronchiolitis; bronchopulmonary dysplasia; palivizumab; prematurity
SDGs
Type
journal article